A patient treated for infeility with clomiphene citrate presents with sudden onset of abdominal pain and distension with ascites. Most probable diagnosis is:
**Core Concept**
Clomiphene citrate is a selective estrogen receptor modulator (SERM) used in the treatment of infertility. It works by stimulating the hypothalamus to release gonadotropin-releasing hormone (GnRH), which in turn stimulates the pituitary gland to release follicle-stimulating hormone (FSH). This leads to increased estrogen production and ovulation.
**Why the Correct Answer is Right**
The sudden onset of abdominal pain, distension, and ascites in a patient treated with clomiphene citrate is most likely due to ovarian hyperstimulation syndrome (OHSS). OHSS is a complication of ovulation induction, characterized by the formation of ovarian cysts and fluid accumulation in the abdominal cavity. This occurs due to the increased estrogen levels, which stimulate the growth of ovarian follicles and lead to the release of vascular endothelial growth factor (VEGF) and other angiogenic factors. The increased capillary permeability and fluid leakage into the abdominal cavity result in ascites and abdominal distension.
**Why Each Wrong Option is Incorrect**
**Option A:** This is not a plausible answer as OHSS is a well-documented complication of ovulation induction, and the symptoms described are consistent with this diagnosis.
**Option B:** There is no direct association between clomiphene citrate and acute pancreatitis, making this option incorrect.
**Option C:** This is not a recognized complication of clomiphene citrate treatment, and the symptoms described do not match this diagnosis.
**Clinical Pearl / High-Yield Fact**
A key aspect of managing OHSS is to avoid further stimulation of the ovaries, which can exacerbate the condition. This can be achieved by withholding clomiphene citrate or other ovulation-inducing medications and using supportive care measures to manage symptoms.
**Correct Answer:** C. Ovarian hyperstimulation syndrome (OHSS).